GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (OTCPK:NVZMF) » Definitions » Valuation Rank

NVZMF (Novonesis (Novozymes) B) Valuation Rank


View and export this data going back to 2009. Start your Free Trial

What is Novonesis (Novozymes) B Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Novonesis (Novozymes) B Valuation Rank Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis (Novozymes) B Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (OTCPK:NVZMF) » Definitions » Valuation Rank
Comparable Companies
OCSE:SPG OCSE:FLUG B OCSE:HOVE LIN XPAR:AI SHW ECL APD XSWX:SIKA ISX:TPIA XSWX:GIVN SHSE:600309 BOM:500820 DD XAMS:DSFIR PPG LYB IFF NSE:PIDILITIND ADX:BOROUGE
Traded in Other Exchanges
NVZMY:USA NSISBc:UK 0Q4U:UK NSIS B:Denmark NZM2:Germany
Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Website
https://www.novozymes.com
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.